nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—CYP3A7—Tacrolimus—atopic dermatitis	0.0558	0.0945	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0558	0.0945	CbGbCtD
Docetaxel—CYP3A5—Tacrolimus—atopic dermatitis	0.0419	0.0709	CbGbCtD
Docetaxel—CYP1B1—Dexamethasone—atopic dermatitis	0.0402	0.0681	CbGbCtD
Docetaxel—ABCG2—Hydrocortisone—atopic dermatitis	0.0308	0.0521	CbGbCtD
Docetaxel—CYP3A4—Pimecrolimus—atopic dermatitis	0.0274	0.0465	CbGbCtD
Docetaxel—ABCB1—Tacrolimus—atopic dermatitis	0.0272	0.0461	CbGbCtD
Docetaxel—CYP3A7—Hydrocortisone—atopic dermatitis	0.0227	0.0385	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0227	0.0385	CbGbCtD
Docetaxel—ABCC2—Dexamethasone—atopic dermatitis	0.0212	0.0358	CbGbCtD
Docetaxel—ABCB1—Loratadine—atopic dermatitis	0.0199	0.0338	CbGbCtD
Docetaxel—ABCG2—Dexamethasone—atopic dermatitis	0.0191	0.0324	CbGbCtD
Docetaxel—ABCB1—Methylprednisolone—atopic dermatitis	0.0182	0.0309	CbGbCtD
Docetaxel—CYP3A5—Hydrocortisone—atopic dermatitis	0.017	0.0289	CbGbCtD
Docetaxel—CYP3A4—Tacrolimus—atopic dermatitis	0.0163	0.0276	CbGbCtD
Docetaxel—CYP3A7—Dexamethasone—atopic dermatitis	0.0141	0.0239	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.0141	0.0239	CbGbCtD
Docetaxel—CYP3A4—Loratadine—atopic dermatitis	0.0119	0.0202	CbGbCtD
Docetaxel—ABCB1—Betamethasone—atopic dermatitis	0.0119	0.0201	CbGbCtD
Docetaxel—ABCB1—Prednisolone—atopic dermatitis	0.0117	0.0198	CbGbCtD
Docetaxel—ABCB1—Hydrocortisone—atopic dermatitis	0.0111	0.0188	CbGbCtD
Docetaxel—ABCB1—Prednisone—atopic dermatitis	0.011	0.0187	CbGbCtD
Docetaxel—CYP3A4—Methylprednisolone—atopic dermatitis	0.0109	0.0185	CbGbCtD
Docetaxel—CYP3A5—Dexamethasone—atopic dermatitis	0.0106	0.0179	CbGbCtD
Docetaxel—CYP3A4—Triamcinolone—atopic dermatitis	0.00828	0.014	CbGbCtD
Docetaxel—CYP3A4—Betamethasone—atopic dermatitis	0.0071	0.012	CbGbCtD
Docetaxel—CYP3A4—Prednisolone—atopic dermatitis	0.00701	0.0119	CbGbCtD
Docetaxel—ABCB1—Dexamethasone—atopic dermatitis	0.0069	0.0117	CbGbCtD
Docetaxel—CYP3A4—Hydrocortisone—atopic dermatitis	0.00664	0.0113	CbGbCtD
Docetaxel—CYP3A4—Prednisone—atopic dermatitis	0.00662	0.0112	CbGbCtD
Docetaxel—CYP3A4—Dexamethasone—atopic dermatitis	0.00413	0.007	CbGbCtD
Docetaxel—GHRHR—head—atopic dermatitis	0.00341	0.0955	CbGeAlD
Docetaxel—TUBB4B—skin epidermis—atopic dermatitis	0.00313	0.0879	CbGeAlD
Docetaxel—BCL2—neck—atopic dermatitis	0.00287	0.0806	CbGeAlD
Docetaxel—MAP2—neck—atopic dermatitis	0.00249	0.0698	CbGeAlD
Docetaxel—MAP4—skin of body—atopic dermatitis	0.00205	0.0574	CbGeAlD
Docetaxel—NR1I2—head—atopic dermatitis	0.00204	0.0572	CbGeAlD
Docetaxel—TUBB8—head—atopic dermatitis	0.00196	0.0549	CbGeAlD
Docetaxel—BCL2—skin of body—atopic dermatitis	0.00186	0.0522	CbGeAlD
Docetaxel—MAP4—head—atopic dermatitis	0.00133	0.0374	CbGeAlD
Docetaxel—TUBB3—head—atopic dermatitis	0.00133	0.0374	CbGeAlD
Docetaxel—TUBB1—head—atopic dermatitis	0.00131	0.0366	CbGeAlD
Docetaxel—TUBB4A—skin of body—atopic dermatitis	0.00124	0.0349	CbGeAlD
Docetaxel—BCL2—head—atopic dermatitis	0.00121	0.034	CbGeAlD
Docetaxel—TUBB2A—skin of body—atopic dermatitis	0.00113	0.0318	CbGeAlD
Docetaxel—TUBB6—skin of body—atopic dermatitis	0.00112	0.0313	CbGeAlD
Docetaxel—MAP2—head—atopic dermatitis	0.00105	0.0295	CbGeAlD
Docetaxel—TUBB6—Dexbrompheniramine—Diphenhydramine—atopic dermatitis	0.00103	0.272	CbGdCrCtD
Docetaxel—TUBB6—Brompheniramine—Diphenhydramine—atopic dermatitis	0.00103	0.272	CbGdCrCtD
Docetaxel—TUBB4B—skin of body—atopic dermatitis	0.000971	0.0272	CbGeAlD
Docetaxel—TUBB4A—head—atopic dermatitis	0.000812	0.0228	CbGeAlD
Docetaxel—TUBB2B—head—atopic dermatitis	0.000785	0.022	CbGeAlD
Docetaxel—CYP1B1—skin of body—atopic dermatitis	0.000769	0.0216	CbGeAlD
Docetaxel—TUBB2A—head—atopic dermatitis	0.000739	0.0207	CbGeAlD
Docetaxel—TUBB6—head—atopic dermatitis	0.000729	0.0204	CbGeAlD
Docetaxel—BCL2—Tamoxifen—Diphenhydramine—atopic dermatitis	0.000699	0.184	CbGdCrCtD
Docetaxel—TUBB4B—head—atopic dermatitis	0.000634	0.0178	CbGeAlD
Docetaxel—CYP1B1—head—atopic dermatitis	0.000502	0.0141	CbGeAlD
Docetaxel—TUBB6—Clomifene—Diphenhydramine—atopic dermatitis	0.000395	0.104	CbGdCrCtD
Docetaxel—TUBB6—Toremifene—Diphenhydramine—atopic dermatitis	0.000385	0.102	CbGdCrCtD
Docetaxel—TUBB6—Tamoxifen—Diphenhydramine—atopic dermatitis	0.000253	0.0668	CbGdCrCtD
Docetaxel—ABCB1—head—atopic dermatitis	0.000184	0.00517	CbGeAlD
Docetaxel—Syncope—Hydrocortisone—atopic dermatitis	0.00012	0.000471	CcSEcCtD
Docetaxel—Diarrhoea—Tacrolimus—atopic dermatitis	0.00012	0.00047	CcSEcCtD
Docetaxel—Angiopathy—Betamethasone—atopic dermatitis	0.000119	0.000467	CcSEcCtD
Docetaxel—Angiopathy—Dexamethasone—atopic dermatitis	0.000119	0.000467	CcSEcCtD
Docetaxel—Convulsion—Prednisolone—atopic dermatitis	0.000119	0.000466	CcSEcCtD
Docetaxel—Hypertension—Prednisolone—atopic dermatitis	0.000118	0.000464	CcSEcCtD
Docetaxel—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000118	0.000461	CcSEcCtD
Docetaxel—Arrhythmia—Betamethasone—atopic dermatitis	0.000117	0.00046	CcSEcCtD
Docetaxel—Arrhythmia—Dexamethasone—atopic dermatitis	0.000117	0.00046	CcSEcCtD
Docetaxel—Alopecia—Dexamethasone—atopic dermatitis	0.000116	0.000455	CcSEcCtD
Docetaxel—Alopecia—Betamethasone—atopic dermatitis	0.000116	0.000455	CcSEcCtD
Docetaxel—Convulsion—Hydrocortisone—atopic dermatitis	0.000116	0.000455	CcSEcCtD
Docetaxel—Dizziness—Tacrolimus—atopic dermatitis	0.000116	0.000454	CcSEcCtD
Docetaxel—Hypertension—Hydrocortisone—atopic dermatitis	0.000115	0.000453	CcSEcCtD
Docetaxel—Haemoglobin—Prednisone—atopic dermatitis	0.000115	0.000451	CcSEcCtD
Docetaxel—Haemorrhage—Prednisone—atopic dermatitis	0.000114	0.000449	CcSEcCtD
Docetaxel—Erythema—Betamethasone—atopic dermatitis	0.000114	0.000448	CcSEcCtD
Docetaxel—Erythema—Dexamethasone—atopic dermatitis	0.000114	0.000448	CcSEcCtD
Docetaxel—Myalgia—Hydrocortisone—atopic dermatitis	0.000114	0.000447	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000113	0.000444	CcSEcCtD
Docetaxel—Syncope—Triamcinolone—atopic dermatitis	0.000113	0.000443	CcSEcCtD
Docetaxel—Syncope—Methylprednisolone—atopic dermatitis	0.000113	0.000442	CcSEcCtD
Docetaxel—Connective tissue disorder—Prednisone—atopic dermatitis	0.000112	0.000441	CcSEcCtD
Docetaxel—Oedema—Prednisolone—atopic dermatitis	0.000112	0.000439	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000112	0.000439	CcSEcCtD
Docetaxel—Vomiting—Tacrolimus—atopic dermatitis	0.000111	0.000437	CcSEcCtD
Docetaxel—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000111	0.000434	CcSEcCtD
Docetaxel—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.00011	0.000433	CcSEcCtD
Docetaxel—Rash—Tacrolimus—atopic dermatitis	0.00011	0.000433	CcSEcCtD
Docetaxel—Dermatitis—Tacrolimus—atopic dermatitis	0.00011	0.000433	CcSEcCtD
Docetaxel—Shock—Prednisolone—atopic dermatitis	0.00011	0.000432	CcSEcCtD
Docetaxel—Cough—Triamcinolone—atopic dermatitis	0.00011	0.000431	CcSEcCtD
Docetaxel—Headache—Tacrolimus—atopic dermatitis	0.00011	0.00043	CcSEcCtD
Docetaxel—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000109	0.000428	CcSEcCtD
Docetaxel—Oedema—Hydrocortisone—atopic dermatitis	0.000109	0.000428	CcSEcCtD
Docetaxel—Convulsion—Triamcinolone—atopic dermatitis	0.000109	0.000428	CcSEcCtD
Docetaxel—Tachycardia—Prednisolone—atopic dermatitis	0.000109	0.000428	CcSEcCtD
Docetaxel—Convulsion—Methylprednisolone—atopic dermatitis	0.000109	0.000427	CcSEcCtD
Docetaxel—Hypertension—Triamcinolone—atopic dermatitis	0.000109	0.000427	CcSEcCtD
Docetaxel—Hypertension—Methylprednisolone—atopic dermatitis	0.000108	0.000426	CcSEcCtD
Docetaxel—Infection—Hydrocortisone—atopic dermatitis	0.000108	0.000426	CcSEcCtD
Docetaxel—Shock—Hydrocortisone—atopic dermatitis	0.000107	0.000422	CcSEcCtD
Docetaxel—Myalgia—Triamcinolone—atopic dermatitis	0.000107	0.000421	CcSEcCtD
Docetaxel—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000107	0.00042	CcSEcCtD
Docetaxel—Myalgia—Methylprednisolone—atopic dermatitis	0.000107	0.00042	CcSEcCtD
Docetaxel—Arthralgia—Methylprednisolone—atopic dermatitis	0.000107	0.00042	CcSEcCtD
Docetaxel—Eye disorder—Prednisone—atopic dermatitis	0.000107	0.000419	CcSEcCtD
Docetaxel—Tachycardia—Hydrocortisone—atopic dermatitis	0.000107	0.000418	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000106	0.000417	CcSEcCtD
Docetaxel—Flushing—Prednisone—atopic dermatitis	0.000106	0.000416	CcSEcCtD
Docetaxel—Skin disorder—Hydrocortisone—atopic dermatitis	0.000106	0.000416	CcSEcCtD
Docetaxel—Dry mouth—Triamcinolone—atopic dermatitis	0.000105	0.000412	CcSEcCtD
Docetaxel—Anorexia—Hydrocortisone—atopic dermatitis	0.000104	0.000408	CcSEcCtD
Docetaxel—Nausea—Tacrolimus—atopic dermatitis	0.000104	0.000408	CcSEcCtD
Docetaxel—Angiopathy—Prednisone—atopic dermatitis	0.000104	0.000407	CcSEcCtD
Docetaxel—Confusional state—Methylprednisolone—atopic dermatitis	0.000103	0.000406	CcSEcCtD
Docetaxel—Immune system disorder—Prednisone—atopic dermatitis	0.000103	0.000405	CcSEcCtD
Docetaxel—Oedema—Triamcinolone—atopic dermatitis	0.000103	0.000403	CcSEcCtD
Docetaxel—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000103	0.000403	CcSEcCtD
Docetaxel—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000103	0.000403	CcSEcCtD
Docetaxel—Syncope—Dexamethasone—atopic dermatitis	0.000102	0.000402	CcSEcCtD
Docetaxel—Syncope—Betamethasone—atopic dermatitis	0.000102	0.000402	CcSEcCtD
Docetaxel—Arrhythmia—Prednisone—atopic dermatitis	0.000102	0.000401	CcSEcCtD
Docetaxel—Infection—Triamcinolone—atopic dermatitis	0.000102	0.000401	CcSEcCtD
Docetaxel—Hypotension—Hydrocortisone—atopic dermatitis	0.000102	0.0004	CcSEcCtD
Docetaxel—Infection—Methylprednisolone—atopic dermatitis	0.000102	0.0004	CcSEcCtD
Docetaxel—Shock—Triamcinolone—atopic dermatitis	0.000101	0.000397	CcSEcCtD
Docetaxel—Insomnia—Prednisolone—atopic dermatitis	0.000101	0.000397	CcSEcCtD
Docetaxel—Alopecia—Prednisone—atopic dermatitis	0.000101	0.000396	CcSEcCtD
Docetaxel—Shock—Methylprednisolone—atopic dermatitis	0.000101	0.000396	CcSEcCtD
Docetaxel—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000101	0.000395	CcSEcCtD
Docetaxel—Loss of consciousness—Betamethasone—atopic dermatitis	0.0001	0.000394	CcSEcCtD
Docetaxel—Loss of consciousness—Dexamethasone—atopic dermatitis	0.0001	0.000394	CcSEcCtD
Docetaxel—Paraesthesia—Prednisolone—atopic dermatitis	0.0001	0.000394	CcSEcCtD
Docetaxel—Tachycardia—Triamcinolone—atopic dermatitis	0.0001	0.000394	CcSEcCtD
Docetaxel—Mental disorder—Prednisone—atopic dermatitis	0.0001	0.000393	CcSEcCtD
Docetaxel—Tachycardia—Methylprednisolone—atopic dermatitis	0.0001	0.000393	CcSEcCtD
Docetaxel—Skin disorder—Methylprednisolone—atopic dermatitis	9.96e-05	0.000391	CcSEcCtD
Docetaxel—Erythema—Prednisone—atopic dermatitis	9.95e-05	0.000391	CcSEcCtD
Docetaxel—Malnutrition—Prednisone—atopic dermatitis	9.95e-05	0.000391	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	9.94e-05	0.00039	CcSEcCtD
Docetaxel—Convulsion—Dexamethasone—atopic dermatitis	9.9e-05	0.000389	CcSEcCtD
Docetaxel—Convulsion—Betamethasone—atopic dermatitis	9.9e-05	0.000389	CcSEcCtD
Docetaxel—Insomnia—Hydrocortisone—atopic dermatitis	9.87e-05	0.000387	CcSEcCtD
Docetaxel—Hypertension—Dexamethasone—atopic dermatitis	9.86e-05	0.000387	CcSEcCtD
Docetaxel—Hypertension—Betamethasone—atopic dermatitis	9.86e-05	0.000387	CcSEcCtD
Docetaxel—Paraesthesia—Hydrocortisone—atopic dermatitis	9.8e-05	0.000385	CcSEcCtD
Docetaxel—Myalgia—Dexamethasone—atopic dermatitis	9.73e-05	0.000382	CcSEcCtD
Docetaxel—Myalgia—Betamethasone—atopic dermatitis	9.73e-05	0.000382	CcSEcCtD
Docetaxel—Dyspepsia—Hydrocortisone—atopic dermatitis	9.61e-05	0.000377	CcSEcCtD
Docetaxel—Hypotension—Methylprednisolone—atopic dermatitis	9.58e-05	0.000376	CcSEcCtD
Docetaxel—Pain—Prednisolone—atopic dermatitis	9.56e-05	0.000375	CcSEcCtD
Docetaxel—Decreased appetite—Hydrocortisone—atopic dermatitis	9.49e-05	0.000372	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	9.42e-05	0.00037	CcSEcCtD
Docetaxel—Fatigue—Hydrocortisone—atopic dermatitis	9.41e-05	0.000369	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	9.36e-05	0.000368	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	9.34e-05	0.000367	CcSEcCtD
Docetaxel—Pain—Hydrocortisone—atopic dermatitis	9.33e-05	0.000366	CcSEcCtD
Docetaxel—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.32e-05	0.000366	CcSEcCtD
Docetaxel—Oedema—Dexamethasone—atopic dermatitis	9.32e-05	0.000366	CcSEcCtD
Docetaxel—Anaphylactic shock—Betamethasone—atopic dermatitis	9.32e-05	0.000366	CcSEcCtD
Docetaxel—Oedema—Betamethasone—atopic dermatitis	9.32e-05	0.000366	CcSEcCtD
Docetaxel—Insomnia—Triamcinolone—atopic dermatitis	9.29e-05	0.000365	CcSEcCtD
Docetaxel—Insomnia—Methylprednisolone—atopic dermatitis	9.27e-05	0.000364	CcSEcCtD
Docetaxel—Infection—Betamethasone—atopic dermatitis	9.26e-05	0.000364	CcSEcCtD
Docetaxel—Infection—Dexamethasone—atopic dermatitis	9.26e-05	0.000364	CcSEcCtD
Docetaxel—Paraesthesia—Triamcinolone—atopic dermatitis	9.23e-05	0.000362	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisolone—atopic dermatitis	9.21e-05	0.000361	CcSEcCtD
Docetaxel—Paraesthesia—Methylprednisolone—atopic dermatitis	9.21e-05	0.000361	CcSEcCtD
Docetaxel—Anaemia—Prednisone—atopic dermatitis	9.2e-05	0.000361	CcSEcCtD
Docetaxel—Shock—Dexamethasone—atopic dermatitis	9.17e-05	0.00036	CcSEcCtD
Docetaxel—Shock—Betamethasone—atopic dermatitis	9.17e-05	0.00036	CcSEcCtD
Docetaxel—Dyspnoea—Triamcinolone—atopic dermatitis	9.16e-05	0.00036	CcSEcCtD
Docetaxel—Nervous system disorder—Betamethasone—atopic dermatitis	9.14e-05	0.000359	CcSEcCtD
Docetaxel—Nervous system disorder—Dexamethasone—atopic dermatitis	9.14e-05	0.000359	CcSEcCtD
Docetaxel—Thrombocytopenia—Betamethasone—atopic dermatitis	9.13e-05	0.000358	CcSEcCtD
Docetaxel—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.13e-05	0.000358	CcSEcCtD
Docetaxel—Tachycardia—Betamethasone—atopic dermatitis	9.1e-05	0.000357	CcSEcCtD
Docetaxel—Tachycardia—Dexamethasone—atopic dermatitis	9.1e-05	0.000357	CcSEcCtD
Docetaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.08e-05	0.000787	CbGpPWpGaD
Docetaxel—Dyspepsia—Triamcinolone—atopic dermatitis	9.05e-05	0.000355	CcSEcCtD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	9.03e-05	0.000783	CbGpPWpGaD
Docetaxel—Dyspepsia—Methylprednisolone—atopic dermatitis	9.03e-05	0.000354	CcSEcCtD
Docetaxel—Feeling abnormal—Hydrocortisone—atopic dermatitis	8.99e-05	0.000353	CcSEcCtD
Docetaxel—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	8.92e-05	0.00035	CcSEcCtD
Docetaxel—Syncope—Prednisone—atopic dermatitis	8.92e-05	0.00035	CcSEcCtD
Docetaxel—Anorexia—Betamethasone—atopic dermatitis	8.89e-05	0.000349	CcSEcCtD
Docetaxel—Anorexia—Dexamethasone—atopic dermatitis	8.89e-05	0.000349	CcSEcCtD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	8.87e-05	0.000769	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	8.86e-05	0.000769	CbGpPWpGaD
Docetaxel—Fatigue—Triamcinolone—atopic dermatitis	8.86e-05	0.000348	CcSEcCtD
Docetaxel—Fatigue—Methylprednisolone—atopic dermatitis	8.84e-05	0.000347	CcSEcCtD
Docetaxel—Pain—Triamcinolone—atopic dermatitis	8.79e-05	0.000345	CcSEcCtD
Docetaxel—Loss of consciousness—Prednisone—atopic dermatitis	8.74e-05	0.000343	CcSEcCtD
Docetaxel—EGFR—MAPK Signaling Pathway—NGF—atopic dermatitis	8.72e-05	0.000756	CbGpPWpGaD
Docetaxel—Hypotension—Betamethasone—atopic dermatitis	8.71e-05	0.000342	CcSEcCtD
Docetaxel—Hypotension—Dexamethasone—atopic dermatitis	8.71e-05	0.000342	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL10—atopic dermatitis	8.66e-05	0.000751	CbGpPWpGaD
Docetaxel—Abdominal pain—Hydrocortisone—atopic dermatitis	8.63e-05	0.000339	CcSEcCtD
Docetaxel—Body temperature increased—Hydrocortisone—atopic dermatitis	8.63e-05	0.000339	CcSEcCtD
Docetaxel—Convulsion—Prednisone—atopic dermatitis	8.62e-05	0.000338	CcSEcCtD
Docetaxel—Hypertension—Prednisone—atopic dermatitis	8.59e-05	0.000337	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—CASP1—atopic dermatitis	8.53e-05	0.00074	CbGpPWpGaD
Docetaxel—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	8.49e-05	0.000333	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	8.49e-05	0.000333	CcSEcCtD
Docetaxel—Myalgia—Prednisone—atopic dermatitis	8.47e-05	0.000333	CcSEcCtD
Docetaxel—Arthralgia—Prednisone—atopic dermatitis	8.47e-05	0.000333	CcSEcCtD
Docetaxel—Feeling abnormal—Triamcinolone—atopic dermatitis	8.47e-05	0.000332	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—CXCL10—atopic dermatitis	8.45e-05	0.000733	CbGpPWpGaD
Docetaxel—Feeling abnormal—Methylprednisolone—atopic dermatitis	8.45e-05	0.000332	CcSEcCtD
Docetaxel—Insomnia—Betamethasone—atopic dermatitis	8.43e-05	0.000331	CcSEcCtD
Docetaxel—Insomnia—Dexamethasone—atopic dermatitis	8.43e-05	0.000331	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL4—atopic dermatitis	8.42e-05	0.00073	CbGpPWpGaD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	8.41e-05	0.00033	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.38e-05	0.000329	CcSEcCtD
Docetaxel—Paraesthesia—Betamethasone—atopic dermatitis	8.37e-05	0.000329	CcSEcCtD
Docetaxel—Paraesthesia—Dexamethasone—atopic dermatitis	8.37e-05	0.000329	CcSEcCtD
Docetaxel—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	8.27e-05	0.000717	CbGpPWpGaD
Docetaxel—Hypersensitivity—Prednisolone—atopic dermatitis	8.23e-05	0.000323	CcSEcCtD
Docetaxel—Dyspepsia—Dexamethasone—atopic dermatitis	8.21e-05	0.000322	CcSEcCtD
Docetaxel—Dyspepsia—Betamethasone—atopic dermatitis	8.21e-05	0.000322	CcSEcCtD
Docetaxel—BCL2—Apoptosis—MAPK8—atopic dermatitis	8.14e-05	0.000706	CbGpPWpGaD
Docetaxel—Body temperature increased—Triamcinolone—atopic dermatitis	8.12e-05	0.000319	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisone—atopic dermatitis	8.12e-05	0.000319	CcSEcCtD
Docetaxel—Oedema—Prednisone—atopic dermatitis	8.12e-05	0.000319	CcSEcCtD
Docetaxel—Abdominal pain—Methylprednisolone—atopic dermatitis	8.11e-05	0.000318	CcSEcCtD
Docetaxel—Decreased appetite—Dexamethasone—atopic dermatitis	8.11e-05	0.000318	CcSEcCtD
Docetaxel—Decreased appetite—Betamethasone—atopic dermatitis	8.11e-05	0.000318	CcSEcCtD
Docetaxel—Infection—Prednisone—atopic dermatitis	8.07e-05	0.000317	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.05e-05	0.000316	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.05e-05	0.000316	CcSEcCtD
Docetaxel—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.04e-05	0.000316	CcSEcCtD
Docetaxel—Fatigue—Dexamethasone—atopic dermatitis	8.04e-05	0.000316	CcSEcCtD
Docetaxel—Fatigue—Betamethasone—atopic dermatitis	8.04e-05	0.000316	CcSEcCtD
Docetaxel—Shock—Prednisone—atopic dermatitis	7.99e-05	0.000314	CcSEcCtD
Docetaxel—Pain—Betamethasone—atopic dermatitis	7.97e-05	0.000313	CcSEcCtD
Docetaxel—Pain—Dexamethasone—atopic dermatitis	7.97e-05	0.000313	CcSEcCtD
Docetaxel—Nervous system disorder—Prednisone—atopic dermatitis	7.96e-05	0.000313	CcSEcCtD
Docetaxel—Tachycardia—Prednisone—atopic dermatitis	7.92e-05	0.000311	CcSEcCtD
Docetaxel—Skin disorder—Prednisone—atopic dermatitis	7.89e-05	0.00031	CcSEcCtD
Docetaxel—Asthenia—Hydrocortisone—atopic dermatitis	7.83e-05	0.000307	CcSEcCtD
Docetaxel—KIF11—Immune System—IFNG—atopic dermatitis	7.75e-05	0.000672	CbGpPWpGaD
Docetaxel—Anorexia—Prednisone—atopic dermatitis	7.74e-05	0.000304	CcSEcCtD
Docetaxel—Pruritus—Hydrocortisone—atopic dermatitis	7.72e-05	0.000303	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—TLR2—atopic dermatitis	7.71e-05	0.000669	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KIF3A—atopic dermatitis	7.71e-05	0.000669	CbGpPWpGaD
Docetaxel—Feeling abnormal—Dexamethasone—atopic dermatitis	7.68e-05	0.000302	CcSEcCtD
Docetaxel—Feeling abnormal—Betamethasone—atopic dermatitis	7.68e-05	0.000302	CcSEcCtD
Docetaxel—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.62e-05	0.000299	CcSEcCtD
Docetaxel—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.62e-05	0.000299	CcSEcCtD
Docetaxel—Hypersensitivity—Triamcinolone—atopic dermatitis	7.57e-05	0.000297	CcSEcCtD
Docetaxel—Hypersensitivity—Methylprednisolone—atopic dermatitis	7.55e-05	0.000297	CcSEcCtD
Docetaxel—EGFR—Adaptive Immune System—KIF3A—atopic dermatitis	7.52e-05	0.000652	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD4—atopic dermatitis	7.49e-05	0.000649	CbGpPWpGaD
Docetaxel—Diarrhoea—Hydrocortisone—atopic dermatitis	7.47e-05	0.000293	CcSEcCtD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	7.41e-05	0.000642	CbGpPWpGaD
Docetaxel—Musculoskeletal discomfort—Prednisone—atopic dermatitis	7.4e-05	0.00029	CcSEcCtD
Docetaxel—Dizziness—Prednisolone—atopic dermatitis	7.39e-05	0.00029	CcSEcCtD
Docetaxel—GHRHR—GPCR downstream signaling—CXCL8—atopic dermatitis	7.39e-05	0.000641	CbGpPWpGaD
Docetaxel—Asthenia—Triamcinolone—atopic dermatitis	7.37e-05	0.000289	CcSEcCtD
Docetaxel—Body temperature increased—Dexamethasone—atopic dermatitis	7.37e-05	0.000289	CcSEcCtD
Docetaxel—Abdominal pain—Dexamethasone—atopic dermatitis	7.37e-05	0.000289	CcSEcCtD
Docetaxel—Abdominal pain—Betamethasone—atopic dermatitis	7.37e-05	0.000289	CcSEcCtD
Docetaxel—Body temperature increased—Betamethasone—atopic dermatitis	7.37e-05	0.000289	CcSEcCtD
Docetaxel—Asthenia—Methylprednisolone—atopic dermatitis	7.36e-05	0.000289	CcSEcCtD
Docetaxel—Insomnia—Prednisone—atopic dermatitis	7.34e-05	0.000288	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—IFNG—atopic dermatitis	7.32e-05	0.000635	CbGpPWpGaD
Docetaxel—Paraesthesia—Prednisone—atopic dermatitis	7.29e-05	0.000286	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—CCL5—atopic dermatitis	7.27e-05	0.000631	CbGpPWpGaD
Docetaxel—Pruritus—Triamcinolone—atopic dermatitis	7.27e-05	0.000285	CcSEcCtD
Docetaxel—Pruritus—Methylprednisolone—atopic dermatitis	7.25e-05	0.000285	CcSEcCtD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NFKBIA—atopic dermatitis	7.23e-05	0.000627	CbGpPWpGaD
Docetaxel—Dizziness—Hydrocortisone—atopic dermatitis	7.22e-05	0.000283	CcSEcCtD
Docetaxel—Dyspepsia—Prednisone—atopic dermatitis	7.15e-05	0.000281	CcSEcCtD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	7.1e-05	0.000615	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	7.07e-05	0.000613	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—IL2—atopic dermatitis	7.06e-05	0.000612	CbGpPWpGaD
Docetaxel—Decreased appetite—Prednisone—atopic dermatitis	7.06e-05	0.000277	CcSEcCtD
Docetaxel—Rash—Prednisolone—atopic dermatitis	7.05e-05	0.000277	CcSEcCtD
Docetaxel—Dermatitis—Prednisolone—atopic dermatitis	7.04e-05	0.000276	CcSEcCtD
Docetaxel—Diarrhoea—Methylprednisolone—atopic dermatitis	7.02e-05	0.000275	CcSEcCtD
Docetaxel—EGFR—Signaling by GPCR—CCL22—atopic dermatitis	7e-05	0.000607	CbGpPWpGaD
Docetaxel—Fatigue—Prednisone—atopic dermatitis	7e-05	0.000275	CcSEcCtD
Docetaxel—Headache—Prednisolone—atopic dermatitis	7e-05	0.000275	CcSEcCtD
Docetaxel—Constipation—Prednisone—atopic dermatitis	6.94e-05	0.000273	CcSEcCtD
Docetaxel—Vomiting—Hydrocortisone—atopic dermatitis	6.94e-05	0.000272	CcSEcCtD
Docetaxel—BCL2—Focal Adhesion—MAPK8—atopic dermatitis	6.92e-05	0.0006	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL1B—atopic dermatitis	6.91e-05	0.0006	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—NFKBIA—atopic dermatitis	6.9e-05	0.000598	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL2—atopic dermatitis	6.89e-05	0.000597	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	6.89e-05	0.000597	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FCER1A—atopic dermatitis	6.88e-05	0.000597	CbGpPWpGaD
Docetaxel—Rash—Hydrocortisone—atopic dermatitis	6.88e-05	0.00027	CcSEcCtD
Docetaxel—Dermatitis—Hydrocortisone—atopic dermatitis	6.87e-05	0.00027	CcSEcCtD
Docetaxel—Headache—Hydrocortisone—atopic dermatitis	6.84e-05	0.000268	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—CXCL8—atopic dermatitis	6.8e-05	0.00059	CbGpPWpGaD
Docetaxel—Dizziness—Triamcinolone—atopic dermatitis	6.8e-05	0.000267	CcSEcCtD
Docetaxel—Dizziness—Methylprednisolone—atopic dermatitis	6.78e-05	0.000266	CcSEcCtD
Docetaxel—EGFR—SHP2 signaling—IL6—atopic dermatitis	6.75e-05	0.000585	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NGF—atopic dermatitis	6.74e-05	0.000584	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—CXCL8—atopic dermatitis	6.71e-05	0.000582	CbGpPWpGaD
Docetaxel—Feeling abnormal—Prednisone—atopic dermatitis	6.69e-05	0.000263	CcSEcCtD
Docetaxel—Asthenia—Betamethasone—atopic dermatitis	6.69e-05	0.000263	CcSEcCtD
Docetaxel—Asthenia—Dexamethasone—atopic dermatitis	6.69e-05	0.000263	CcSEcCtD
Docetaxel—EGFR—Innate Immune System—STAT6—atopic dermatitis	6.65e-05	0.000577	CbGpPWpGaD
Docetaxel—Gastrointestinal pain—Prednisone—atopic dermatitis	6.64e-05	0.000261	CcSEcCtD
Docetaxel—Nausea—Prednisolone—atopic dermatitis	6.64e-05	0.000261	CcSEcCtD
Docetaxel—Pruritus—Dexamethasone—atopic dermatitis	6.6e-05	0.000259	CcSEcCtD
Docetaxel—Pruritus—Betamethasone—atopic dermatitis	6.6e-05	0.000259	CcSEcCtD
Docetaxel—EGFR—ErbB1 downstream signaling—MAPK8—atopic dermatitis	6.57e-05	0.00057	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT6—atopic dermatitis	6.56e-05	0.000569	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCR5—atopic dermatitis	6.55e-05	0.000568	CbGpPWpGaD
Docetaxel—Vomiting—Triamcinolone—atopic dermatitis	6.53e-05	0.000256	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—IL1B—atopic dermatitis	6.53e-05	0.000566	CbGpPWpGaD
Docetaxel—Vomiting—Methylprednisolone—atopic dermatitis	6.52e-05	0.000256	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—IL2—atopic dermatitis	6.5e-05	0.000564	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	6.49e-05	0.000563	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—CASP8—atopic dermatitis	6.49e-05	0.000563	CbGpPWpGaD
Docetaxel—Nausea—Hydrocortisone—atopic dermatitis	6.48e-05	0.000254	CcSEcCtD
Docetaxel—Rash—Triamcinolone—atopic dermatitis	6.48e-05	0.000254	CcSEcCtD
Docetaxel—EGFR—Innate Immune System—CARD11—atopic dermatitis	6.47e-05	0.000561	CbGpPWpGaD
Docetaxel—Dermatitis—Triamcinolone—atopic dermatitis	6.47e-05	0.000254	CcSEcCtD
Docetaxel—Rash—Methylprednisolone—atopic dermatitis	6.46e-05	0.000254	CcSEcCtD
Docetaxel—Dermatitis—Methylprednisolone—atopic dermatitis	6.46e-05	0.000254	CcSEcCtD
Docetaxel—ABCC2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.46e-05	0.00056	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.44e-05	0.000559	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.44e-05	0.000559	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—atopic dermatitis	6.44e-05	0.000559	CbGpPWpGaD
Docetaxel—Headache—Triamcinolone—atopic dermatitis	6.44e-05	0.000253	CcSEcCtD
Docetaxel—Headache—Methylprednisolone—atopic dermatitis	6.42e-05	0.000252	CcSEcCtD
Docetaxel—Abdominal pain—Prednisone—atopic dermatitis	6.42e-05	0.000252	CcSEcCtD
Docetaxel—Body temperature increased—Prednisone—atopic dermatitis	6.42e-05	0.000252	CcSEcCtD
Docetaxel—GHRHR—Signaling by GPCR—IL2—atopic dermatitis	6.41e-05	0.000556	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MS4A2—atopic dermatitis	6.4e-05	0.000555	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—NFKBIA—atopic dermatitis	6.38e-05	0.000554	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.38e-05	0.000553	CbGpPWpGaD
Docetaxel—Diarrhoea—Dexamethasone—atopic dermatitis	6.38e-05	0.00025	CcSEcCtD
Docetaxel—Diarrhoea—Betamethasone—atopic dermatitis	6.38e-05	0.00025	CcSEcCtD
Docetaxel—BCL2—Immune System—CARD11—atopic dermatitis	6.38e-05	0.000553	CbGpPWpGaD
Docetaxel—KIF11—Immune System—MAPK8—atopic dermatitis	6.34e-05	0.00055	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GLB1—atopic dermatitis	6.31e-05	0.000547	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL27—atopic dermatitis	6.24e-05	0.000541	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.22e-05	0.00054	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CARD11—atopic dermatitis	6.22e-05	0.000539	CbGpPWpGaD
Docetaxel—Dizziness—Dexamethasone—atopic dermatitis	6.17e-05	0.000242	CcSEcCtD
Docetaxel—Dizziness—Betamethasone—atopic dermatitis	6.17e-05	0.000242	CcSEcCtD
Docetaxel—Nausea—Triamcinolone—atopic dermatitis	6.1e-05	0.00024	CcSEcCtD
Docetaxel—Nausea—Methylprednisolone—atopic dermatitis	6.09e-05	0.000239	CcSEcCtD
Docetaxel—SLCO1B3—Metabolism—ADSL—atopic dermatitis	6.05e-05	0.000525	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.03e-05	0.000523	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	5.99e-05	0.000519	CbGpPWpGaD
Docetaxel—Hypersensitivity—Prednisone—atopic dermatitis	5.98e-05	0.000235	CcSEcCtD
Docetaxel—Vomiting—Betamethasone—atopic dermatitis	5.93e-05	0.000233	CcSEcCtD
Docetaxel—Vomiting—Dexamethasone—atopic dermatitis	5.93e-05	0.000233	CcSEcCtD
Docetaxel—TUBB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.89e-05	0.000511	CbGpPWpGaD
Docetaxel—Rash—Betamethasone—atopic dermatitis	5.88e-05	0.000231	CcSEcCtD
Docetaxel—Rash—Dexamethasone—atopic dermatitis	5.88e-05	0.000231	CcSEcCtD
Docetaxel—Dermatitis—Dexamethasone—atopic dermatitis	5.87e-05	0.000231	CcSEcCtD
Docetaxel—Dermatitis—Betamethasone—atopic dermatitis	5.87e-05	0.000231	CcSEcCtD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	5.85e-05	0.000508	CbGpPWpGaD
Docetaxel—Headache—Dexamethasone—atopic dermatitis	5.84e-05	0.000229	CcSEcCtD
Docetaxel—Headache—Betamethasone—atopic dermatitis	5.84e-05	0.000229	CcSEcCtD
Docetaxel—Asthenia—Prednisone—atopic dermatitis	5.83e-05	0.000229	CcSEcCtD
Docetaxel—Pruritus—Prednisone—atopic dermatitis	5.74e-05	0.000226	CcSEcCtD
Docetaxel—EGFR—Immune System—DEFB1—atopic dermatitis	5.7e-05	0.000494	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NGF—atopic dermatitis	5.7e-05	0.000494	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.62e-05	0.000487	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL17—atopic dermatitis	5.6e-05	0.000485	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NFKBIA—atopic dermatitis	5.56e-05	0.000482	CbGpPWpGaD
Docetaxel—Diarrhoea—Prednisone—atopic dermatitis	5.56e-05	0.000218	CcSEcCtD
Docetaxel—Nausea—Dexamethasone—atopic dermatitis	5.54e-05	0.000217	CcSEcCtD
Docetaxel—Nausea—Betamethasone—atopic dermatitis	5.54e-05	0.000217	CcSEcCtD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	5.45e-05	0.000473	CbGpPWpGaD
Docetaxel—Dizziness—Prednisone—atopic dermatitis	5.37e-05	0.000211	CcSEcCtD
Docetaxel—ABCC1—Disease—GLB1—atopic dermatitis	5.33e-05	0.000462	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.29e-05	0.000459	CbGpPWpGaD
Docetaxel—Vomiting—Prednisone—atopic dermatitis	5.16e-05	0.000203	CcSEcCtD
Docetaxel—Rash—Prednisone—atopic dermatitis	5.12e-05	0.000201	CcSEcCtD
Docetaxel—Dermatitis—Prednisone—atopic dermatitis	5.11e-05	0.000201	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	5.09e-05	0.000442	CbGpPWpGaD
Docetaxel—Headache—Prednisone—atopic dermatitis	5.09e-05	0.0002	CcSEcCtD
Docetaxel—EGFR—Innate Immune System—CASP1—atopic dermatitis	5.04e-05	0.000437	CbGpPWpGaD
Docetaxel—EGFR—Disease—GLB1—atopic dermatitis	5.02e-05	0.000436	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CASP1—atopic dermatitis	4.97e-05	0.000431	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—IL1B—atopic dermatitis	4.92e-05	0.000427	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.84e-05	0.00042	CbGpPWpGaD
Docetaxel—Nausea—Prednisone—atopic dermatitis	4.82e-05	0.000189	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—TNF—atopic dermatitis	4.74e-05	0.000411	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	4.73e-05	0.000411	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—PPARA—atopic dermatitis	4.72e-05	0.000409	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL5—atopic dermatitis	4.71e-05	0.000408	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NFKBIA—atopic dermatitis	4.7e-05	0.000407	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	4.64e-05	0.000403	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.6e-05	0.000399	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.6e-05	0.000399	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TLR2—atopic dermatitis	4.56e-05	0.000396	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KIF3A—atopic dermatitis	4.56e-05	0.000395	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	4.54e-05	0.000394	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NFKBIA—atopic dermatitis	4.53e-05	0.000393	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL2—atopic dermatitis	4.52e-05	0.000392	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL11—atopic dermatitis	4.51e-05	0.000391	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—MAPK8—atopic dermatitis	4.51e-05	0.000391	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TLR2—atopic dermatitis	4.49e-05	0.00039	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.48e-05	0.000388	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GLB1—atopic dermatitis	4.46e-05	0.000387	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FCER2—atopic dermatitis	4.45e-05	0.000386	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.37e-05	0.000379	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	4.33e-05	0.000375	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GLB1—atopic dermatitis	4.32e-05	0.000374	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ADSL—atopic dermatitis	4.28e-05	0.000371	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD79A—atopic dermatitis	4.22e-05	0.000366	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ADSL—atopic dermatitis	4.14e-05	0.000359	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL22—atopic dermatitis	4.14e-05	0.000359	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD79A—atopic dermatitis	4.12e-05	0.000357	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CASP8—atopic dermatitis	4.09e-05	0.000355	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—MAPK8—atopic dermatitis	4.09e-05	0.000355	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	4.07e-05	0.000353	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL6—atopic dermatitis	4.05e-05	0.000351	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CXCL8—atopic dermatitis	3.96e-05	0.000344	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GLB1—atopic dermatitis	3.93e-05	0.000341	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GLB1—atopic dermatitis	3.89e-05	0.000338	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT6—atopic dermatitis	3.88e-05	0.000336	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL6—atopic dermatitis	3.82e-05	0.000331	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL2—atopic dermatitis	3.79e-05	0.000328	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CARD11—atopic dermatitis	3.77e-05	0.000327	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL6—atopic dermatitis	3.77e-05	0.000327	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ADSL—atopic dermatitis	3.76e-05	0.000326	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ADSL—atopic dermatitis	3.73e-05	0.000324	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CXCL8—atopic dermatitis	3.69e-05	0.00032	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CXCL8—atopic dermatitis	3.69e-05	0.00032	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL27—atopic dermatitis	3.69e-05	0.00032	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCR3—atopic dermatitis	3.68e-05	0.000319	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—atopic dermatitis	3.57e-05	0.00031	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SLC11A1—atopic dermatitis	3.57e-05	0.00031	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CXCL8—atopic dermatitis	3.57e-05	0.000309	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MAPK8—atopic dermatitis	3.49e-05	0.000302	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL18—atopic dermatitis	3.46e-05	0.0003	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CXCL8—atopic dermatitis	3.45e-05	0.0003	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—PPARA—atopic dermatitis	3.43e-05	0.000298	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—atopic dermatitis	3.41e-05	0.000295	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CXCL8—atopic dermatitis	3.38e-05	0.000293	CbGpPWpGaD
Docetaxel—EGFR—Disease—SLC11A1—atopic dermatitis	3.36e-05	0.000292	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD4—atopic dermatitis	3.36e-05	0.000291	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—atopic dermatitis	3.32e-05	0.000288	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—IL6—atopic dermatitis	3.31e-05	0.000287	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL17—atopic dermatitis	3.31e-05	0.000287	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—atopic dermatitis	3.3e-05	0.000286	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TAC1—atopic dermatitis	3.28e-05	0.000284	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NPS—atopic dermatitis	3.28e-05	0.000284	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.28e-05	0.000284	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.25e-05	0.000282	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.22e-05	0.000279	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCR3—atopic dermatitis	3.21e-05	0.000279	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—IL6—atopic dermatitis	3.17e-05	0.000275	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.15e-05	0.000273	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.13e-05	0.000271	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—IL6—atopic dermatitis	3.12e-05	0.000271	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.09e-05	0.000268	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL5—atopic dermatitis	3.05e-05	0.000264	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.04e-05	0.000263	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CXCL8—atopic dermatitis	3.03e-05	0.000263	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—IL6—atopic dermatitis	2.98e-05	0.000258	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—IL6—atopic dermatitis	2.97e-05	0.000257	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.95e-05	0.000256	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—IL6—atopic dermatitis	2.95e-05	0.000256	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—MAPK8—atopic dermatitis	2.95e-05	0.000256	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KIF3A—atopic dermatitis	2.95e-05	0.000256	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CASP1—atopic dermatitis	2.94e-05	0.000255	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—IL6—atopic dermatitis	2.94e-05	0.000255	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MAPK8—atopic dermatitis	2.84e-05	0.000247	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GLB1—atopic dermatitis	2.81e-05	0.000244	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL5—atopic dermatitis	2.78e-05	0.000241	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CXCL8—atopic dermatitis	2.77e-05	0.000241	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—IL6—atopic dermatitis	2.76e-05	0.00024	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—IL6—atopic dermatitis	2.76e-05	0.00024	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	2.76e-05	0.00024	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—IL6—atopic dermatitis	2.74e-05	0.000237	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.72e-05	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—IL6—atopic dermatitis	2.71e-05	0.000235	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—IL6—atopic dermatitis	2.7e-05	0.000234	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADSL—atopic dermatitis	2.7e-05	0.000234	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NFKBIA—atopic dermatitis	2.68e-05	0.000232	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL11—atopic dermatitis	2.67e-05	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CMA1—atopic dermatitis	2.67e-05	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR2—atopic dermatitis	2.66e-05	0.00023	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NFKBIA—atopic dermatitis	2.64e-05	0.000229	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL10—atopic dermatitis	2.6e-05	0.000225	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NFKBIA—atopic dermatitis	2.57e-05	0.000223	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT6—atopic dermatitis	2.51e-05	0.000217	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD79A—atopic dermatitis	2.5e-05	0.000217	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	2.45e-05	0.000212	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CASP8—atopic dermatitis	2.42e-05	0.00021	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CASP8—atopic dermatitis	2.38e-05	0.000207	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.37e-05	0.000205	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL5—atopic dermatitis	2.24e-05	0.000194	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—atopic dermatitis	2.23e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR3—atopic dermatitis	2.17e-05	0.000188	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GLB1—atopic dermatitis	2.12e-05	0.000184	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.06e-05	0.000178	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PPARA—atopic dermatitis	2.05e-05	0.000178	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL18—atopic dermatitis	2.04e-05	0.000177	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADSL—atopic dermatitis	2.04e-05	0.000176	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFNG—atopic dermatitis	2.03e-05	0.000176	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCR5—atopic dermatitis	2.02e-05	0.000175	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—atopic dermatitis	2.01e-05	0.000175	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—atopic dermatitis	1.99e-05	0.000172	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—atopic dermatitis	1.96e-05	0.00017	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NPS—atopic dermatitis	1.94e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TAC1—atopic dermatitis	1.94e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—atopic dermatitis	1.91e-05	0.000165	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCR3—atopic dermatitis	1.9e-05	0.000165	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—atopic dermatitis	1.88e-05	0.000163	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—atopic dermatitis	1.82e-05	0.000157	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—atopic dermatitis	1.81e-05	0.000157	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CCR5—atopic dermatitis	1.8e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL5—atopic dermatitis	1.8e-05	0.000156	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—atopic dermatitis	1.8e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—atopic dermatitis	1.7e-05	0.000148	CbGpPWpGaD
Docetaxel—EGFR—Disease—CCR5—atopic dermatitis	1.7e-05	0.000147	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK8—atopic dermatitis	1.68e-05	0.000146	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK8—atopic dermatitis	1.66e-05	0.000144	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.63e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NFKBIA—atopic dermatitis	1.56e-05	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL10—atopic dermatitis	1.54e-05	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—atopic dermatitis	1.51e-05	0.000131	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.47e-05	0.000128	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARA—atopic dermatitis	1.45e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CASP8—atopic dermatitis	1.41e-05	0.000122	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARA—atopic dermatitis	1.4e-05	0.000121	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL5—atopic dermatitis	1.32e-05	0.000115	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.31e-05	0.000113	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARA—atopic dermatitis	1.27e-05	0.000111	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARA—atopic dermatitis	1.26e-05	0.00011	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.25e-05	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NGF—atopic dermatitis	1.22e-05	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—atopic dermatitis	1.22e-05	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—atopic dermatitis	1.22e-05	0.000105	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—atopic dermatitis	1.2e-05	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR5—atopic dermatitis	1.19e-05	0.000103	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—atopic dermatitis	1.16e-05	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—atopic dermatitis	1.16e-05	0.0001	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—atopic dermatitis	1.13e-05	9.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—atopic dermatitis	1.07e-05	9.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—atopic dermatitis	1.07e-05	9.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—atopic dermatitis	1.07e-05	9.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—atopic dermatitis	1.06e-05	9.23e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—atopic dermatitis	1.06e-05	9.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NFKBIA—atopic dermatitis	1.01e-05	8.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK8—atopic dermatitis	9.79e-06	8.49e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARA—atopic dermatitis	9.13e-06	7.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—atopic dermatitis	7.2e-06	6.24e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARA—atopic dermatitis	6.89e-06	5.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—atopic dermatitis	6.88e-06	5.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—atopic dermatitis	6.84e-06	5.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK8—atopic dermatitis	6.33e-06	5.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—atopic dermatitis	6.25e-06	5.42e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—atopic dermatitis	6.13e-06	5.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—atopic dermatitis	5.77e-06	5.01e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.24e-06	3.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—atopic dermatitis	4.04e-06	3.51e-05	CbGpPWpGaD
